The two NF-κB activation pathways and their role in innate and adaptive immunity

Trends in Immunology

Volumn 25, Issue 6, 2004, Pages 280-288

  Bonizzi, Giuseppina ^a   Karin, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 8; KAPPA OPIATE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN BCL 3; PROTEIN SUBUNIT; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR REL; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR ALPHA; CHUK PROTEIN, MOUSE; CYTOKINE; IKBKB PROTEIN, MOUSE; IKBKE PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE;

AMINO TERMINAL SEQUENCE; APOPTOSIS; B LYMPHOCYTE; BINDING SITE; BONE MARROW CELL; CELL MATURATION; CELL POPULATION; CELL TYPE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOPLASM; ENZYME ACTIVITY; FOLLICULAR DENDRITIC CELL; GENE CONTROL; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNIZATION; INFLAMMATION; LYMPH NODE; LYMPHOID CELL; LYMPHOID ORGAN; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ORGANOGENESIS; PEYER PATCH; PHAGOCYTE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SPLEEN; TRANSPLANTATION; TRYPANOSOMA CRUZI; ADAPTATION; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOID TISSUE; METABOLISM; MOUSE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CYTOKINES; I-KAPPA B KINASE; IMMUNITY, NATURAL; LYMPHOID TISSUE; MICE; MODELS, IMMUNOLOGICAL; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 2342464085     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2004.03.008     Document Type: Review

References (64)

1. Ghosh S., et al. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:1998;225-260
2. Ryseck R.P., et al. RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol. Cell. Biol. 12:1992;674-684
3. Ruben S.M., et al. I-Rel: a novel rel-related protein that inhibits NF-κB transcriptional activity. Genes Dev. 6:1992;745-760
4. Mercurio F., et al. p105 and p98 precursor proteins play an active role in NF-κB mediated signal transduction. Genes Dev. 7:1993;705-718
5. Ghosh S., Karin M. Missing pieces in the NF-κB puzzle. Cell. 109:2002;S81-S96
6. Senftleben U., et al. Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway. Science. 293:2001;1495-1499
7. Dejardin E., et al. The lymphotoxin-β receptor induces different patterns of gene expression via two NF-κB pathways. Immunity. 17:2002;525-535
8. Xiao G., et al. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell. 7:2001;401-409
9. Mordmuller B., et al. Lymphotoxin and lipopolysaccharide induce NF-κB-p52 generation by a co-translational mechanism. EMBO Rep. 4:2003;82-87
10. Alcamo E., et al. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment. J. Immunol. 167:2001;1592-1600
11. Senftleben U., et al. IKKβ is essential for protecting T cells from TNFα-induced apoptosis. Immunity. 14:2001;217-230
12. Elewaut D., et al. NF-κB is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. J. Immunol. 163:1999;1457-1466
13. Wickremasinghe M.I., et al. Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-κB-dependent network. J. Immunol. 163:1999;3936-3947
14. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:2001;135-145
15. Gewirtz A.T., et al. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167:2001;1882-1885
16. Hemmi H., et al. A Toll-like receptor recognizes bacterial DNA. Nature. 408:2000;740-745
17. Alexopoulou L., et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature. 413:2001;732-738
18. Caamano J., et al. The NF-κB family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J. Immunol. 163:1999;4453-4461
19. Grigoriadis G., et al. The Rel subunit of NF-κB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EMBO J. 15:1996;7099-7107
20. Mason N., et al. Cutting edge: identification of c-Rel-dependent and -independent pathways of IL-12 production during infectious and inflammatory stimuli. J. Immunol. 168:2002;2590-2594
21. Scott P., Trinchieri G. The role of natural killer cells in host-parasite interactions. Curr. Opin. Immunol. 7:1995;34-40
22. Hsu L.-C., et al. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature. 248:2004;341-345
23. Orth K., et al. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science. 290:2000;1594-1597
24. Doi T.S., et al. NF-κB RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185:1997;953-961
25. Li Q., et al. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science. 284:1999;321-325
26. Maeda S., et al. IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα Immunity. 19:2003;725-737
27. Li Z.-W., et al. IKKβ is required for peripheral B cell proliferation and survival. J. Immunol. 170:2003;4630-4637
28. Horwitz B.H., et al. Failure of lymphopoiesis after adoptive transfer of NF-κB-deficient fetal liver cells. Immunity. 6:1997;765-772
29. Voll R.E., et al. NF-κB activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity. 13:2000;677-689
30. Grossmann M., et al. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. EMBO J. 19:2000;6351-6360
31. Weih F., et al. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen. Oncogene. 9:1994;3289-3297
32. Sha W.C., et al. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80:1995;321-330
33. Weih D.S., et al. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J. Immunol. 167:2001;1909-1919
34. Tumang J.R., et al. c-Rel is essential for B lymphocyte survival and cell cycle progression. Eur. J. Immunol. 28:1998;4299-4312
35. Shinkura R., et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding NF-κB-inducing kinase. Nat. Genet. 22:1999;74-77
36. Yamada T., et al. Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-κB-inducing kinase. J. Immunol. 165:2000;804-812
37. Caamano J.H., et al. NF-κB (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J. Exp. Med. 187:1998;185-196
38. Matsushima A., et al. Essential role of nuclear factor NF-κB-inducing kinase and inhibitor of κB (IκB) kinase alpha in NF-κB activation through LTβR, but not through TNFR1. J. Exp. Med. 193:2001;631-636
39. Bours V., et al. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell. 72:1993;729-739
40. Poljak L., et al. Distinct activities of p52/NF-κB required for proper secondary lymphoid organ microarchitecture: functions enhanced by Bcl-3. J. Immunol. 163:1999;6581-6588
41. Cyster J.G. B cells on the front line. Nat. Immunol. 1:2000;9-10
42. Franzoso G., et al. Mice deficient in NF-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic reactions. J. Exp. Med. 187:1998;147-159
43. Franzoso G., et al. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. Immunity. 6:1997;479-490
44. Alcamo E., et al. Requirement for the NF-κB family member RelA in the development of secondary lymphoid organs. J. Exp. Med. 195:2002;233-244
45. Matsumoto M. Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting. J. Med. Invest. 46:1999;141-150
46. Cariappa A., et al. NF-κB is required for the development of marginal zone B lymphocytes. J. Exp. Med. 192:2000;1175-1182
47. Fu Y.X., Chaplin D.D. Development and maturation of secondary lymphoid tissues. Annu. Rev. Immunol. 17:1999;399-433
48. Miyawaki S., et al. A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice. Eur. J. Immunol. 24:1994;429-434
49. Yilmaz Z.B., et al. RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF. EMBO J. 22:2003;121-130
50. Weih F., Caamano J. Regulation of secondary lymphoid organ development by the NF-κB signal transduction pathway. Immunol. Rev. 195:2003;91-105
51. Claudio E., et al. BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells. Nat. Immunol. 3:2002;958-965
52. Coope H.J., et al. CD40 regulates the processing of NF-κB2 p100 to p52. EMBO J. 21:2002;5375-5385
53. Ansel K.M., et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature. 406:2000;309-314
54. Mackay F., Browning J.L. BAFF: a fundamental survival factor for B cells. Nat. Rev. Immunol. 2:2002;465-475
55. Noelle R.J. CD40 and its ligand in cell-mediated immunity. Agents Actions Suppl. 49:1998;17-22
56. Schiemann B., et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science. 293:2001;2111-2114
57. Miosge L.A., et al. Analysis of an ethylnitrosourea-generated mouse mutation defines a cell intrinsic role ofNF-κB2 in regulating circulating B cell numbers. J. Exp. Med. 196:2002;1113-1119
58. Rothwarf D.M., et al. IKKγ is an essential regulatory subunit of the IκB kinase complex. Nature. 395:1998;297-300
59. May M.J., et al. Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex. Science. 289:2000;1550-1554
60. Zandi E., et al. Direct phosphorylation of IκB by IKKα and IKKβ: Discrimination between free and NF-κB-bound substrate. Science. 281:1998;1360-1363
61. Chen L.-W., et al. The two faces of IKK and NF-κB inhibition: Prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 9:2003;575-581
62. Silverman N., et al. A Drosphila IκB kinase complex required for Relish cleavage and antibacterial immunity. Genes Dev. 14:2000;2461-2471
63. Cyster J.G. Homing of antibody secreting cells. Immunol. Rev. 194:2003;48-60
64. Makris C., et al. Female mice heterozygote for IKKγ/NEMO deficiencies develop a genodermatosis similar to the human X-linked disorder Incontinentia Pigmenti. Mol. Cell. 5:2000;969-979